| Ytd | 16.24% | |
| 1y | 24.08% |
| Open | 7.77 | Prev Close | 7.80 | Low | 7.61 | High | 7.83 | Mkt Cap | 510.57M |
| Vol | 430.13K | Avg Vol | 900.79K | EPS | -0.53 | P/E | N/A | Forward P/E | 54.20 |
| Beta | 1.31 | Short Ratio | 7.38 | Inst. Own | 80.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 7.97 | 200-d Avg | 6.17 | 1yr Est | 23.43 |
EOLS News
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
The U.S. Food and Drug Administration's Office of Prescription Drug Promotion in September issued a
The FDA has warned Evolus that an Instagram post for Jeuveau is false or misleading and misbrands th
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com
BlackRock Inc. acquired a new stake in shares of Evolus, Inc. (NASDAQ: EOLS) during the second quart
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Me
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix" or the "Company") today
The mean of analysts' price targets for Evolus (EOLS) points to a 77.7% upside in the stock. While t
HC Wainwright & Co. analyst Douglas Tsao reiterates Evolus (NASDAQ:EOLS) with a Buy and maint
Evolus, Inc. (NASDAQ: EOLS - Get Free Report)'s stock price reached a new 52-week high during mid-da
Assenagon Asset Management S.A. lifted its holdings in Evolus, Inc. (NASDAQ: EOLS) by 51.8% in the u
The average of price targets set by Wall Street analysts indicates a potential upside of 106.1% in E
Evolus is evolving into a multi-product aesthetics platform, leveraging its distribution network and
Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript
Evolus, Inc. (EOLS) reported break-even quarterly earnings per share versus the Zacks Consensus Esti
Evolus NASDAQ: EOLS reported second-quarter revenue growth of 21% and raised the lower end of its fu
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.12) per share which beat the analyst consensus
Evolus (NASDAQ:EOLS) raises FY2026 sales outlook from $327.000 million-$337.000 million to $330.000
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com
[url="]Evolus, Inc.[/url] (NASDAQ: EOLS), a global performance beauty company with a focus on buildi
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi
Evolus, Inc. (NASDAQ:EOLS), a global performance beauty company with a focus on building an aestheti
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com
https://www.sec.gov/Archives/edgar/data/1570562/000157056226000071/evoluss-32026.htm
US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 resu
eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, v
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the c
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. He
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat